Silver Book Fact

Investments in cancer research and development between 1998 and 2000 has generated 23 million additional healthy years of life and $1.9 trillion of additional social value.

Lakdawala, D, E Sun, A Jena, C Reyes, D Goldman, et al. An Economic Evaluation of the War on Cancer. J Health Econ. 2010; 29(3): 333-46. http://www.sciencedirect.com/science/article/B6V8K-4YH567G-1/2/88c88fbdd7f57d9fe08803ec85397bc0

Reference

Title
An Economic Evaluation of the War on Cancer
Publication
J Health Econ
Publication Date
2010
Authors
Lakdawala, D, E Sun, A Jena, C Reyes, D Goldman, et al.
Volume & Issue
Volume 29, Issue 3
Pages
333-46
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • For women age 40 or older, timely mammograms could reduce breast cancer mortality by about 16%–compared to those who are not screened.  
  • The use of imatinib (Gleevec) has increased the eight-year survival rate for early chronic-phase myelogenous leukemia from 65% to 84%.  
  • According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets late-stage metastatic melanoma. The medicine contains a gene encoding antigen that may be able to…  
  • Image-guided breast biopsy takes about 1/5 the of a surgical biopsy, reduces complications and allows women to commence daily activities in 1/2 the time that it takes after open surgery.…  
  • Widespread use of telomerase inhibitors could result in a 50% cure rate and a 25% prolongation of life for 50% of eligible patients with solid tumors.